REPL
Replimune Group Inc
Price:  
8.77 
USD
Volume:  
1,349,366.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Fair Value

-269.07 %
Upside

What is the fair value of REPL?

As of 2025-04-23, the Fair Value of Replimune Group Inc (REPL) is -14.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.77 USD, the upside of Replimune Group Inc is -269.07%.

Is REPL a good investment?

With the market price of 8.77 USD and our fair value calculation, Replimune Group Inc (REPL) is not a good investment. Investing in REPL stocks now will result in a potential loss of 269.07%.

Note: valuation result may not be accurate due to the company's negative EPS.

8.77 USD
Stock Price
-14.82 USD
Fair Price
FAIR VALUE CALCULATION

REPL Fair Value

Peter Lynch's formula is:

REPL Fair Value
= Earnings Growth Rate x TTM EPS
REPL Fair Value
= 5.00 x -2.96
REPL Fair Value
= -14.82

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31 5Y Avg
Net income -52.63 -80.87 -118.04 -174.28 -215.79 -128.32
YoY growth -70.71% -53.66% -45.96% -47.64% -23.82% -48.36%

REPL Fair Value - Key Data

Market Cap (mil) 674.99
P/E
Forward P/E
EPS -2.96
Avg earnings growth rate -48.36%
TTM earnings -228.24